POLR2E is a shared subunit among RNA polymerases I, II, and III, contributing to their structural and functional stability. It is part of the lower jaw domain of Pol II, which binds the DNA template during transcription . The gene encoding POLR2E is located on human chromosome 19 and has a pseudogene on chromosome 11 .
| Feature | Description |
|---|---|
| Molecular Weight | 25 kDa |
| Gene Locus | Chromosome 19q13.33 |
| Interactions | Binds transcription factors (e.g., TAF15) and other Pol II subunits |
POLR2E is implicated in autoimmune diseases like scleroderma, where autoantibodies target RNA polymerase II. Research indicates that the carboxyl-terminal domain (CTD) of Pol II’s largest subunit contains epitopes recognized by these autoantibodies . POLR2E antibodies are used in diagnostic assays to detect such autoimmune markers .
POLR2E antibodies are employed in:
Transcriptional Studies: Investigating RNA Pol II dynamics and chromatin interactions .
Disease Diagnosis: Detecting scleroderma-associated autoantibodies .
Subcellular Localization: Identifying Pol II in nucleus and cytoplasm via IHC/IF .
Autoimmune Epitopes: The CTD of Pol II’s largest subunit is a dominant target for autoantibodies in scleroderma .
Expression Patterns: POLR2E is ubiquitously expressed in human tissues, with high levels in kidney and liver .
Therapeutic Potential: Inhibiting POLR2E interactions may modulate transcriptional activity in cancer or autoimmune conditions .